ID VIP1_MOUSE Reviewed; 1436 AA. AC A2ARP1; A2ARP2; A2ARP3; A2ARP4; Q6P1C8; Q7TSP1; Q80U21; Q8BL16; Q8BUN6; AC Q8BVG9; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 20-FEB-2007, sequence version 1. DT 24-JAN-2024, entry version 128. DE RecName: Full=Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 {ECO:0000305}; DE EC=2.7.4.24 {ECO:0000250|UniProtKB:Q6PFW1}; DE AltName: Full=Diphosphoinositol pentakisphosphate kinase 1; DE AltName: Full=Histidine acid phosphatase domain-containing protein 2A; DE AltName: Full=InsP6 and PP-IP5 kinase 1; DE AltName: Full=VIP1 homolog; GN Name=Ppip5k1 {ECO:0000312|MGI:MGI:2443281}; GN Synonyms=Hisppd2a, Kiaa0377, Vip1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=Swiss Webster; TISSUE=Brain; RA Avidan N., Dgany O.D., Cattan D.C., Pariente A., Thulliez M., Borot N., RA Moati L., Alain B., Krasnov T., Olender T., Shalmon L., Ben-Asher E., RA Khen M., Shalev H., Fellous M., Delaunay J., Yaniv I., Zaizov R., RA Beckmann J.S., Lancet D., Tamary H.; RT "A 60kb genomic deletion is associated with non-syndromic deafness and RT sperm motility disorder but not with congenital dyserythropoietic anemia RT type I."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=12693553; DOI=10.1093/dnares/10.1.35; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S., RA Nakajima D., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: II. RT The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:35-48(2003). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 6). RC STRAIN=C57BL/6J; RC TISSUE=Adipose tissue, Hippocampus, and Olfactory bulb; RX PubMed=16141072; DOI=10.1126/science.1112014; RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.; RT "The transcriptional landscape of the mammalian genome."; RL Science 309:1559-1563(2005). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5). RC STRAIN=C57BL/6J; TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1140 AND SER-1147, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, Kidney, and Lung; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Bifunctional inositol kinase that acts in concert with the CC IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate CC group-containing inositol pyrophosphates diphosphoinositol CC pentakisphosphate, PP-InsP5, and bis-diphosphoinositol CC tetrakisphosphate, (PP)2-InsP4. PP-InsP5 and (PP)2-InsP4, also CC respectively called InsP7 and InsP8, regulate a variety of cellular CC processes, including apoptosis, vesicle trafficking, cytoskeletal CC dynamics, exocytosis, insulin signaling and neutrophil activation. CC Phosphorylates inositol hexakisphosphate (InsP6) at position 1 to CC produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce CC (PP)2-InsP4. Alternatively, phosphorylates PP-InsP5 at position 1, CC produced by IP6Ks from InsP6, to produce (PP)2-InsP4. Activated when CC cells are exposed to hyperosmotic stress. CC {ECO:0000250|UniProtKB:Q6PFW1}. CC -!- CATALYTIC ACTIVITY: CC Reaction=1D-myo-inositol hexakisphosphate + ATP = 1-diphospho-1D-myo- CC inositol 2,3,4,5,6-pentakisphosphate + ADP; Xref=Rhea:RHEA:37459, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:58130, ChEBI:CHEBI:74946, CC ChEBI:CHEBI:456216; EC=2.7.4.24; CC Evidence={ECO:0000250|UniProtKB:Q6PFW1}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37460; CC Evidence={ECO:0000250|UniProtKB:Q6PFW1}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate + ATP CC + H(+) = 1,5-bis(diphospho)-1D-myo-inositol 2,3,4,6-tetrakisphosphate CC + ADP; Xref=Rhea:RHEA:10276, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:58628, ChEBI:CHEBI:77983, ChEBI:CHEBI:456216; CC EC=2.7.4.24; Evidence={ECO:0000250|UniProtKB:Q6PFW1}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10277; CC Evidence={ECO:0000250|UniProtKB:Q6PFW1}; CC -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol CC {ECO:0000250|UniProtKB:Q6PFW1}. Cell membrane CC {ECO:0000250|UniProtKB:Q6PFW1}. Note=Relocalizes to the plasma membrane CC upon activation of the PtdIns 3-kinase pathway. CC {ECO:0000250|UniProtKB:Q6PFW1}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=6; CC Name=1; CC IsoId=A2ARP1-1; Sequence=Displayed; CC Name=2; CC IsoId=A2ARP1-2; Sequence=VSP_030631; CC Name=3; CC IsoId=A2ARP1-3; Sequence=VSP_030634; CC Name=4; CC IsoId=A2ARP1-5; Sequence=VSP_030625, VSP_030626; CC Name=5; CC IsoId=A2ARP1-6; Sequence=VSP_030627, VSP_030628; CC Name=6; CC IsoId=A2ARP1-7; Sequence=VSP_030629, VSP_030630; CC -!- DOMAIN: The C-terminal acid phosphatase-like domain binds CC PtdIns(3,4,5)P3 and InsP6. Despite its similarity with the phosphatase CC domain of histidine acid phosphatases, it has no phosphatase activity. CC {ECO:0000250|UniProtKB:Q6PFW1}. CC -!- SIMILARITY: Belongs to the histidine acid phosphatase family. VIP1 CC subfamily. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC32838.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305}; CC Sequence=BAC37198.1; Type=Frameshift; Evidence={ECO:0000305}; CC Sequence=BAC65546.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF502585; AAP46293.1; -; mRNA. DR EMBL; AK122264; BAC65546.1; ALT_INIT; mRNA. DR EMBL; AK046696; BAC32838.1; ALT_SEQ; mRNA. DR EMBL; AK078268; BAC37198.1; ALT_FRAME; mRNA. DR EMBL; AK083140; BAC38780.1; -; mRNA. DR EMBL; AL845466; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC065138; AAH65138.1; -; mRNA. DR CCDS; CCDS16639.1; -. [A2ARP1-1] DR RefSeq; NP_848910.3; NM_178795.4. [A2ARP1-1] DR RefSeq; XP_006499804.1; XM_006499741.3. DR RefSeq; XP_011237919.1; XM_011239617.2. DR AlphaFoldDB; A2ARP1; -. DR SMR; A2ARP1; -. DR BioGRID; 236476; 3. DR STRING; 10090.ENSMUSP00000057632; -. DR iPTMnet; A2ARP1; -. DR PhosphoSitePlus; A2ARP1; -. DR SwissPalm; A2ARP1; -. DR MaxQB; A2ARP1; -. DR PaxDb; 10090-ENSMUSP00000106256; -. DR PeptideAtlas; A2ARP1; -. DR ProteomicsDB; 297913; -. [A2ARP1-1] DR ProteomicsDB; 297914; -. [A2ARP1-2] DR ProteomicsDB; 297915; -. [A2ARP1-3] DR ProteomicsDB; 297916; -. [A2ARP1-5] DR ProteomicsDB; 297917; -. [A2ARP1-6] DR ProteomicsDB; 297918; -. [A2ARP1-7] DR Pumba; A2ARP1; -. DR Antibodypedia; 35179; 69 antibodies from 15 providers. DR DNASU; 327655; -. DR Ensembl; ENSMUST00000052029.10; ENSMUSP00000057632.4; ENSMUSG00000033526.17. [A2ARP1-1] DR Ensembl; ENSMUST00000110625.8; ENSMUSP00000106255.2; ENSMUSG00000033526.17. [A2ARP1-3] DR Ensembl; ENSMUST00000110626.8; ENSMUSP00000106256.2; ENSMUSG00000033526.17. [A2ARP1-1] DR Ensembl; ENSMUST00000110627.8; ENSMUSP00000106257.2; ENSMUSG00000033526.17. [A2ARP1-3] DR Ensembl; ENSMUST00000110628.8; ENSMUSP00000106258.2; ENSMUSG00000033526.17. [A2ARP1-2] DR GeneID; 327655; -. DR KEGG; mmu:327655; -. DR UCSC; uc008lyl.1; mouse. [A2ARP1-1] DR UCSC; uc008lyq.1; mouse. [A2ARP1-7] DR UCSC; uc008lyr.1; mouse. [A2ARP1-5] DR UCSC; uc008lys.1; mouse. [A2ARP1-6] DR AGR; MGI:2443281; -. DR CTD; 9677; -. DR MGI; MGI:2443281; Ppip5k1. DR VEuPathDB; HostDB:ENSMUSG00000033526; -. DR eggNOG; KOG1057; Eukaryota. DR GeneTree; ENSGT00390000009048; -. DR HOGENOM; CLU_000914_0_0_1; -. DR InParanoid; A2ARP1; -. DR OMA; AWPRCDA; -. DR OrthoDB; 5476261at2759; -. DR PhylomeDB; A2ARP1; -. DR TreeFam; TF313594; -. DR Reactome; R-MMU-1855167; Synthesis of pyrophosphates in the cytosol. DR BioGRID-ORCS; 327655; 2 hits in 76 CRISPR screens. DR PRO; PR:A2ARP1; -. DR Proteomes; UP000000589; Chromosome 2. DR RNAct; A2ARP1; Protein. DR Bgee; ENSMUSG00000033526; Expressed in retinal neural layer and 221 other cell types or tissues. DR ExpressionAtlas; A2ARP1; baseline and differential. DR GO; GO:0005829; C:cytosol; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; ISO:MGI. DR GO; GO:0005524; F:ATP binding; ISS:UniProtKB. DR GO; GO:0033857; F:diphosphoinositol-pentakisphosphate kinase activity; ISS:UniProtKB. DR GO; GO:0000829; F:inositol heptakisphosphate kinase activity; IBA:GO_Central. DR GO; GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IEA:UniProtKB-EC. DR GO; GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IEA:UniProtKB-EC. DR GO; GO:0000832; F:inositol hexakisphosphate 5-kinase activity; ISS:UniProtKB. DR GO; GO:0000828; F:inositol hexakisphosphate kinase activity; ISS:UniProtKB. DR GO; GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; ISS:UniProtKB. DR GO; GO:0006020; P:inositol metabolic process; ISS:UniProtKB. DR GO; GO:0032958; P:inositol phosphate biosynthetic process; IBA:GO_Central. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR CDD; cd07061; HP_HAP_like; 1. DR Gene3D; 3.40.50.11950; -; 1. DR Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1. DR Gene3D; 3.40.50.1240; Phosphoglycerate mutase-like; 1. DR InterPro; IPR033379; Acid_Pase_AS. DR InterPro; IPR000560; His_Pase_clade-2. DR InterPro; IPR037446; His_Pase_VIP1. DR InterPro; IPR029033; His_PPase_superfam. DR InterPro; IPR040557; VIP1_N. DR PANTHER; PTHR12750; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE; 1. DR PANTHER; PTHR12750:SF11; INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL-PENTAKISPHOSPHATE KINASE 1; 1. DR Pfam; PF00328; His_Phos_2; 1. DR Pfam; PF18086; PPIP5K2_N; 1. DR SUPFAM; SSF53254; Phosphoglycerate mutase-like; 1. DR PROSITE; PS00616; HIS_ACID_PHOSPHAT_1; 1. DR Genevisible; A2ARP1; MM. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Cell membrane; Cytoplasm; Kinase; KW Membrane; Nucleotide-binding; Phosphoprotein; Reference proteome; KW Transferase. FT CHAIN 1..1436 FT /note="Inositol hexakisphosphate and diphosphoinositol- FT pentakisphosphate kinase 1" FT /id="PRO_0000315689" FT REGION 382..453 FT /note="Polyphosphoinositide-binding domain" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT REGION 915..998 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1131..1191 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1389..1436 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 983..998 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1161..1191 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1411..1428 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 64..65 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 145 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 198 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 205 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 224..225 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 224 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 248..251 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 257..259 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 259 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 273 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 275 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 320 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 332..334 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 337..340 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT MOD_RES 939 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT MOD_RES 982 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT MOD_RES 1032 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT MOD_RES 1068 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT MOD_RES 1140 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 1147 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT VAR_SEQ 261..266 FT /note="YTVGPD -> MVDAEI (in isoform 4)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_030625" FT VAR_SEQ 267..1436 FT /note="Missing (in isoform 4)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_030626" FT VAR_SEQ 403..439 FT /note="RTPKQKMKMEVTHPRFFALFEKHGGYKTGKLKLKRPE -> HPSFVIEKLVP FT WRCCLKLHLQDLVATVCFHLHGHQQR (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_030627" FT VAR_SEQ 440..1436 FT /note="Missing (in isoform 5)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_030628" FT VAR_SEQ 653..671 FT /note="LAPTGSTSLLNSMSVIQNP -> VTLFSSPCSNYIATQFLKF (in FT isoform 6)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_030629" FT VAR_SEQ 672..1436 FT /note="Missing (in isoform 6)" FT /evidence="ECO:0000303|PubMed:16141072" FT /id="VSP_030630" FT VAR_SEQ 818..837 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_030631" FT VAR_SEQ 1057..1077 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000305" FT /id="VSP_030634" FT CONFLICT 441 FT /note="L -> I (in Ref. 3; BAC38780)" FT /evidence="ECO:0000305" FT CONFLICT 831 FT /note="T -> A (in Ref. 3; BAC32838)" FT /evidence="ECO:0000305" FT CONFLICT 1049 FT /note="P -> S (in Ref. 2; BAC65546)" FT /evidence="ECO:0000305" FT CONFLICT 1180 FT /note="T -> A (in Ref. 1; AAP46293 and 2; BAC65546)" FT /evidence="ECO:0000305" SQ SEQUENCE 1436 AA; 159923 MW; D160DDDA7F34B4F2 CRC64; MWSLTANEDE STTAHFFLGA GDEGLGTCGI GMRTEESDSE LLEDEEDEVP PEPQIIVGIC AMTKKSKSKP MTQILERLCR FDYLTVVILG EDVILNEPVE NWPSCHCLIS FHSKGFPLDK AVAYSKLRNP FLINDLAMQY YIQDRREVYR ILQEEGIDLP RYAVLNRDPA CPEECSLIEG EDQVEVNGAV FPKPFVEKPV SAEDHNVYIY YPSSAGGGSQ RLFRKIGSRS SVYSPESSVR KTGSYIYEEF MPTDGTDVKV YTVGPDYAHA EARKSPALDG KVERDSEGKE VRYPVMLTAM EKLVARKVCV AFKQTVCGFD LLRANGHSFV CDVNGFSFVK NSMKYYDDCA KILGNTIMRE LAPQFQIPWS IPTEAEDIPI VPTTSGTMME LRCVIAIIRH GDRTPKQKMK MEVTHPRFFA LFEKHGGYKT GKLKLKRPEQ LQEVLDITRL LLAELEKEPE AEIEEKTGKL EQLKSVLEMY GHFSGINRKV QLTYYPHGVK ASNEGQDLQR EPLAPSLLLV LKWGGELTPD GRVQAEELGR AFRCMYPGGQ GDYAGFPGCG LLRLHSTFRH DLKIYASDEG RVQMTAAAFA KGLLALEGEL TPILVQMVKS ANMNGLLDSD SDSLSSCQHR VKARLHHILQ QDAPFGPEDY DQLAPTGSTS LLNSMSVIQN PVKVCDQVFA LIENLTHQIR ERMQDPSSVD LQLYHSETLE LMLQRWSKLE RDFRQKSGRY DISKIPDIYD CVKYDVQHNG SLGLQGTAEL LRLSKALADV VIPQEYGISR EEKVEIAVGF CLPLLRKILL DLQRTHEDES VNKLHPLYSR GVLSPGRHVR TRLYFTSESH VHSLLSVFRY GGLLDETQDA QWQRALAYLS AISELNYMTQ IVIMLYEDNT RDPLSEERFH VELHFSPGVK GVEEGSAPAG CGFRPASSEN EEMKTDPGSI ENLCPGKASD EPDRALQTSP QPVEGTGLPR RSPLIRNRKA GSMEVLSETS SSRPGGYRLF SSSRPPTEMK QSGLGSQCTG LFSTTVLGGS SSAPNLQDYA RTHGKKLPPA SLKHRDELLF VPAVKRFSVS FAKHPTNGFE GCSMVPTIYP LETLHNALSL RQVSEFLTKV CQRHTDAHAQ ASAALFDSMH NHQASDSPFS PPRTLHSPPL QLRHRSEKPP WYSSGPSSTV SSAGPSSPTT VDGNSHFGFS DQSSVNIHMT EEKQGFGLLQ ETPGDGTREL HIERQQELVE PAQSPQELPV EICPSGSQGV TKVSQTCQEV PDIVQPCHNI HEEIGQPQQE VPDISQLLLK DHDTTTNTCH LCQASQLSQK VCEEICQLCQ DNHEESNQLC QEVSVKLGRM VHGFPVNVDS TAQETLMEIG RPTQEIPEDP YQEFSVKVGV LAQKAPAISE LSQDIPEADK PSQELSEETE LQAQEVSEEI DQESEVVDEL PPEAIS //